Evidence map›Paper›PMID 30169818›Full record

ArticleToxicological sciences : an official journal of the Society of Toxicology2019

Functional and Mechanistic Neurotoxicity Profiling Using Human iPSC-Derived Neural 3D Cultures.

Oksana Sirenko, Frederick Parham, Steven Dea, Neha Sodhi, Steven Biesmans, Sergio Mora-Castilla, Kristen Ryan, Mamta Behl, Grischa Chandy, Carole Crittenden and 5 more

Abstract read
In one paragraph

Article in Toxicological sciences : an official journal of the Society of Toxicology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Modulation of CaScientific reports · 2024
    Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Oksana SirenkoMolecular Devices LLC, San Jose, California 95134.
Frederick ParhamDivision of the National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina.
Steven DeaStemoniX, Inc, Maple Grove, Minnesota 55311.
Neha SodhiStemoniX, Inc, Maple Grove, Minnesota 55311.
Steven BiesmansStemoniX, Inc, Maple Grove, Minnesota 55311.
Sergio Mora-CastillaStemoniX, Inc, Maple Grove, Minnesota 55311.
Kristen RyanDivision of the National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina.
Mamta BehlDivision of the National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina.
Grischa ChandyMolecular Devices LLC, San Jose, California 95134.
Carole CrittendenMolecular Devices LLC, San Jose, California 95134.
Sarah Vargas-HurlstonMolecular Devices LLC, San Jose, California 95134.
Oivin GuicheritStemoniX, Inc, Maple Grove, Minnesota 55311.
Ryan GordonStemoniX, Inc, Maple Grove, Minnesota 55311.
Fabian ZanellaStemoniX, Inc, Maple Grove, Minnesota 55311.
Cassiano CarromeuStemoniX, Inc, Maple Grove, Minnesota 55311.

Funding

Toxicological Assessments for the National Toxicology ProgramZIAES103316 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI WALKER, NIGEL J · 2016 to 2019
$31.9M
Biomolecular Screening and Alternative Approaches for the National Toxicology ProgramZIAES103318 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI CASEY, WARREN · 2016 to 2021
$25.0M
6 · The paper itself

Abstract

Neurological disorders affect millions of people worldwide and appear to be on the rise. Whereas the reason for this increase remains unknown, environmental factors are a suspected contributor. Hence, there is an urgent need to develop more complex, biologically relevant, and predictive in vitro assays to screen larger sets of compounds with the potential for neurotoxicity. Here, we employed a human induced pluripotent stem cell (iPSC)-based 3D neural platform composed of mature cortical neurons and astrocytes as a model for this purpose. The iPSC-derived human 3D cortical neuron/astrocyte co-cultures (3D neural cultures) present spontaneous synchronized, readily detectable calcium oscillations. This advanced neural platform was optimized for high-throughput screening in 384-well plates and displays highly consistent, functional performance across different wells and plates. Characterization of oscillation profiles in 3D neural cultures was performed through multi-parametric analysis that included the calcium oscillation rate and peak width, amplitude, and waveform irregularities. Cellular and mitochondrial toxicity were assessed by high-content imaging. For assay characterization, we used a set of neuromodulators with known mechanisms of action. We then explored the neurotoxic profile of a library of 87 compounds that included pharmaceutical drugs, pesticides, flame retardants, and other chemicals. Our results demonstrated that 57% of the tested compounds exhibited effects in the assay. The compounds were then ranked according to their effective concentrations based on in vitro activity. Our results show that a human iPSC-derived 3D neural culture assay platform is a promising biologically relevant tool to assess the neurotoxic potential of drugs and environmental toxicants.

Indexed as

AstrocytesCalcium SignalingCells, CulturedCoculture TechniquesDose-Response Relationship, DrugGene ExpressionHazardous SubstancesHigh-Throughput Screening AssaysHumansInduced Pluripotent Stem CellsNeuronsNeurotoxicity SyndromesSmall Molecule LibrariesToxicity TestsHazardous SubstancesSmall Molecule Libraries

Identifiers

PMID30169818
PMCPMC6317428

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.